Last update 11 Oct 2025

WO2024086317

Patent Mining

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
MARK4
Action
inhibitors
Mechanism
MARK4 inhibitors(microtubule affinity regulating kinase 4 inhibitors)
Therapeutic Areas
Nervous System DiseasesCongenital DisordersEye Diseases+ [1]
Active Indication
Age Related Macular DegenerationCognitive DysfunctionNervous System Diseases
Inactive Indication-
Originator Organization
United States Department of Veterans AffairsUnited States Department of Veterans AffairsThe Regents of the University of CaliforniaThe Regents of the University of California
Active Organization
The Regents of the University of CaliforniaThe Regents of the University of CaliforniaUnited States Department of Veterans AffairsUnited States Department of Veterans Affairs
Inactive Organization-
License Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with WO2024086317
Login to view more data
100 Translational Medicine associated with WO2024086317
Login to view more data
100 Patents (Medical) associated with WO2024086317
Login to view more data
100 Deals associated with WO2024086317
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Age Related Macular DegenerationDiscovery-
United States Department of Veterans AffairsUnited States Department of Veterans Affairs
25 Apr 2024
Age Related Macular DegenerationDiscovery-
The Regents of the University of CaliforniaThe Regents of the University of California
25 Apr 2024
Cognitive DysfunctionDiscovery-
The Regents of the University of CaliforniaThe Regents of the University of California
25 Apr 2024
Cognitive DysfunctionDiscovery-
United States Department of Veterans AffairsUnited States Department of Veterans Affairs
25 Apr 2024
Nervous System DiseasesDiscovery-
The Regents of the University of CaliforniaThe Regents of the University of California
25 Apr 2024
Nervous System DiseasesDiscovery-
United States Department of Veterans AffairsUnited States Department of Veterans Affairs
25 Apr 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free